Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.

https://www.wired.com/story/novo-nordisk-ozempic-compounded-fda-block-pharmacies/

#Wired